Status:
NOT_YET_RECRUITING
Non-Invasive Prediction of Necrotizing Enterocolitis in Preterm Neonates with Feeding Intolerance Using Fecal Lipocalin-2 and Electrical Cardiometry
Lead Sponsor:
Ain Shams University
Conditions:
Feeding Intolerance in Preterm
NEC
Eligibility:
All Genders
1-28 years
Brief Summary
Prospective observational study to evaluate the efficiency of using electrical cardiometry in combination with fecal lipocalin-2 for prediction of NEC in preterm neonates with feeding intolerance
Detailed Description
Necrotizing enterocolitis is one of the most life-threatening conditions for premature infants in neonatal intensive care units (NICU) and is associated with severe intestinal inflammation and necrosi...
Eligibility Criteria
Inclusion
- Preterm neonates with gestational age ≤ 35 weeks, admitted to NICU, started enteral feeding and diagnosed as having feeding intolerance defined as stage IA and IB by modified bell's staging
Exclusion
- Chromosomal anomaly or multiple congenital malformations.
- Patient with surgical malformation of the intestinal tract (i.e. omphalocele, gastroschisis, malrotation, intestinal atresia)
- Patient diagnosed as hypoxic ischemic encephalopathy.
Key Trial Info
Start Date :
March 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 5 2026
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06874153
Start Date
March 5 2025
End Date
June 5 2026
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of medicine, Ain Shams university.
Cairo, Abbasia, Egypt, 11517